Univercells Technologies agreed to collaborate with Repligen to integrate real-time monitoring capabilities and enhance the development and manufacturing of viral vectors and vaccines. Repligen’s ...

Bioreactor and cell retention technology integration features a single direct control interface to simplify intensified seed train implementation Customers experience optimized facility equipment ...

Sartorius and Repligen launched an integrated bioreactor system that incorporates Repligen’s XCell ® ATF upstream intensification technology into Sartorius’ Biostat STR ® bioreactor designed to ...

WALTHAM, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced it has entered into an ...

WALTHAM, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading bioprocessing-focused company delivering technology innovation to improve biologic drug manufacturing ...